GNI Group (TSE:2160) Research & Development: 円3,544 Mil (TTM As of Mar. 2026)


TSE:2160 GNI Group Ltd TSE:2160
84 GF Score
Price 円2,517.00
GF Value 円2,777.99
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is GNI Group Research & Development?

GNI Group TSE:2160 -2.52% 84 Research & Development is 円3,544 Mil as of Mar. 2026. GuruFocus rates TSE:2160 with a GF Score™ of 84/100 and a GF Value™ of 円2,777.99 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. GNI Group's Research & Development for the three months ended in Mar. 2026 was 円1,053 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円3,544 Mil.

GNI Group  (TSE:2160) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

GNI Group Research & Development Related Terms

GNI Group Research & Development Historical Data

* Premium members only.

The historical data trend for GNI Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GNI Group Research & Development Chart

GNI Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,015.88 2,545.46 2,557.80 2,811.00 3,298.00

GNI Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 806.59 789.94 849.47 852.00 1,053.00
TSE:2160
84GF Score
GNI Group Ltd TSE:2160
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GNI Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円3,544 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円3,544 Mil mean?
GNI Group (TSE:2160) has a Research & Development of 円3,544 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on GNI Group and its competitors.
Is GNI Group's Research & Development too high?
GNI Group's current Research & Development is 円3,544 Mil. Overall, GNI Group has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GNI Group's Research & Development compare to VRTX and REGN?
GNI Group's Research & Development of 円3,544 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on GNI Group and its competitors. GNI Group's current Research & Development is 円3,544 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GNI Group stock overvalued right now?
Based on GuruFocus' analysis, GNI Group (TSE:2160) is currently considered Fairly Valued. The stock's GF Value™ is 円2,777.99, compared to a current price of 円2,517.00 — trading 9.4% below its estimated fair value. The current Research & Development is 円3,544 Mil. GNI Group's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For GNI Group (TSE:2160), the current Research & Development is 円3,544 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GNI Group (TSE:2160) Overvalued in 2026?

Based on GuruFocus' analysis, GNI Group stock appears to be undervalued. The current stock price of 円2,517.00 is trading 9.4% below its estimated GF Value™ of 円2,777.99. GuruFocus considers GNI Group to be Fairly Valued.

Key valuation signals for TSE:2160:

  • Research & Development: 円3,544 Mil
  • GF Value™: 円2,777.99 vs. price of 円2,517.00 (9.4% below fair value)
  • GF Score™: 84/100 with 5 warning signs

No single metric tells the full story. See the TSE:2160 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GNI Group Business Description

Address 2-2-2 Nihonbashi Honcho, 3rd Floor, Nihonbashi Honcho YS Building, Chuo-ku, Tokyo, JPN, 103-0023
GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.
84GF Score

Get the complete analysis for TSE:2160

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,517.00
Price
円2,777.99
GF Value